- Home
- PESI vs OBIO Comparison
PESI vs OBIO Comparison
Compare PESI & OBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PESI | OBIO |
|---|---|---|
| Founded | 1990 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Environmental Services | Medicinal Chemicals and Botanical Products |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 243.9M | 237.2M |
| IPO Year | 1992 | N/A |
Fundamental Metrics
Financial Performance| Metric | PESI | OBIO |
|---|---|---|
| Price | $14.62 | $4.21 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $14.25 |
| AVG Volume (30 Days) | 98.1K | ★ 217.8K |
| Earning Date | 11-10-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $60,661,000.00 | $2,818,000.00 |
| Revenue This Year | $9.91 | $35.75 |
| Revenue Next Year | $62.48 | $3.07 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 6.46 |
| 52 Week Low | $6.25 | $2.20 |
| 52 Week High | $16.50 | $6.16 |
Technical Indicators
Market Signals| Indicator | PESI | OBIO |
|---|---|---|
| Relative Strength Index (RSI) | 63.43 | 45.38 |
| Support Level | $14.24 | $4.06 |
| Resistance Level | $14.88 | $4.53 |
| Average True Range (ATR) | 0.61 | 0.30 |
| MACD | 0.15 | -0.03 |
| Stochastic Oscillator | 89.17 | 24.88 |
Price Performance
Historical ComparisonAbout PESI Perma-Fix Environmental Services Inc.
Perma-Fix Environmental Services Inc is a provider of both nuclear services and the management of nuclear and mixed waste. The company operates through two segments: The treatment segment offers nuclear, low-level radioactive, Mixed, hazardous and non-hazardous waste treatment, processing and disposal services, and the Services segment which generates the majority of the revenue, provides on-site waste management services to commercial and government customers, technology-based services, construction, logistics, and transportation services among others.
About OBIO Orchestra BioMed Holdings Inc.
Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.